Polyclonal Increase in Immunoglobulins on SPEP

Clinical Significance and Differential Diagnosis

• Polyclonal hypergammaglobulinemia on SPEP appears as a broad-based elevation in the gamma region, representing increased production of multiple immunoglobulin types from many different plasma cell clones, as noted by the American Thoracic Society 1, 2
• In patients with bronchiectasis, a polyclonal rise in serum IgG and IgA commonly reflects chronic infection and inflammation, according to the American Thoracic Society 1, 2
• Immunodeficiency syndromes can be a cause of polyclonal hypergammaglobulinemia, as reported by the American Thoracic Society 2

Distinguishing from Monoclonal Gammopathies

• It is essential to differentiate polyclonal increases from monoclonal gammopathies, which appear as discrete peaks on SPEP and may indicate multiple myeloma, Waldenström's macroglobulinemia, or monoclonal gammopathy of undetermined significance (MGUS), as recommended by the National Comprehensive Cancer Network 3, 4
• Serum immunofixation electrophoresis (SIFE) should be performed when there is suspicion of a monoclonal protein to confirm whether the increase is truly polyclonal or monoclonal, as suggested by the National Comprehensive Cancer Network 4, 5

Diagnostic Approach

• Evaluation for autoimmune disorders with appropriate serologic testing should be considered when a polyclonal increase in immunoglobulins is identified, as recommended by the American Thoracic Society 1
• Assessment for chronic infections should be performed when a polyclonal increase in immunoglobulins is identified, as recommended by the American Thoracic Society 1, 2

Clinical Implications

• In patients with polyneuropathy, polyclonal increases in immunoglobulins should be distinguished from monoclonal gammopathies, which occur in approximately 10% of patients with polyneuropathy of unknown etiology, as reported by the American Academy of Physical Medicine and Rehabilitation 6, 7

Monitoring and Follow-up

• If clinical suspicion for a monoclonal process remains high despite apparent polyclonal increase on SPEP, more sensitive testing such as immunofixation electrophoresis (IFE) or serum free light chain assay should be considered, as recommended by the National Comprehensive Cancer Network 4, 5

Polyclonal Increase in Multiple Immunoglobulins

Clinical Significance

• Chronic inflammation, such as bronchiectasis, frequently shows polyclonal rises in serum IgG and IgA, according to the Thorax journal 8

Differential Diagnosis

Common Causes

• Chronic inflammation, such as bronchiectasis, can trigger polyclonal increases in immunoglobulins, as reported in the Thorax journal 8

Distinguishing from Monoclonal Gammopathies

• In renal disease and polyclonal B-cell activation, there may be increased levels of both κ and λ light chains, but with a normal ratio, unlike in monoclonal disorders, as stated in the Haematologica journal 9

Clinical Implications and Complications

• Polyclonal hypergammaglobulinemia is associated with increased risk of infections, thrombosis, and bone disorders, such as osteoporosis and fractures, according to the Haematologica journal 10

Diagnostic Approach

Specialized Testing

• Bone marrow examination may be necessary if a hematologic disorder is suspected, as indicated in the Haematologica journal 9
• Functional antibody testing may be required if immunodeficiency is suspected, as mentioned in the Thorax journal 8

Distinguishing Polyclonal from Monoclonal Gammopathies

Definition and Pathophysiology

• Polyclonal gammopathy is characterized by a broad elevation of many different antibody types produced by multiple immune‑cell clones, whereas monoclonal gammopathy (e.g., multiple myeloma) results from a single abnormal clone generating one type of protein. This distinction is outlined in the Haematologica 2014 article. 11

Bone Marrow Findings

• Bone‑marrow evaluation in patients with polyclonal gammopathy shows a normal, diverse population of plasma cells rather than a dominant abnormal clone, as reported in Haematologica 2014. 11

Malignancy Risk

• Evidence to date indicates that polyclonal gammopathy does not progress to multiple myeloma, lymphoma, or other plasma‑cell cancers; no transformation has been documented in the cited literature (Haematologica 2014). 11

Evaluation and Management of Elevated IgG Levels

Diagnostic Confirmation of Polyclonal vs. Monoclonal Patterns

• Serum immunofixation electrophoresis (SIFE) should be performed to definitively exclude a monoclonal protein because it is more sensitive than standard electrophoresis for detecting small monoclonal spikes. 12
• The presence of a discrete monoclonal protein on immunofixation warrants urgent referral to hematology for further work‑up. 12

Comprehensive Immunoglobulin Assessment

• Quantitative measurement of IgA and IgM together with IgG helps differentiate polyclonal from monoclonal processes; polyclonal inflammation typically raises multiple immunoglobulin classes, whereas monoclonal gammopathy usually affects only one. 12

Serum Free Light Chain (FLC) Interpretation

• A serum free‑light‑chain assay should be obtained, reporting κ and λ concentrations and the κ:λ ratio. A normal ratio (≈ 0.26–1.65) supports a polyclonal etiology, while an abnormal ratio suggests a monoclonal disorder. 12
• In patients with moderate to severe chronic kidney disease, the reference range for the κ:λ ratio widens (≈ 0.34–3.10), and this adjustment must be applied to avoid false‑positive monoclonal interpretation. 12

Renal Function Considerations

• Assessment of renal function (serum creatinine/eGFR) is essential because impaired clearance alters free‑light‑chain levels and the κ:λ ratio, influencing the interpretation of the FLC assay. 12
• Unexplained proteinuria or a progressive decline in renal function should prompt evaluation for monoclonal gammopathy of renal significance. 13

Investigation of Underlying Causes of Polyclonal IgG Elevation

• Chronic respiratory infections (e.g., bronchiectasis, chronic sinusitis, osteomyelitis, endocarditis) are common drivers of polyclonal IgG and IgA elevation. 14
• HIV infection predisposes to hypergammaglobulinemia and recurrent infections and should be screened for in the work‑up. 14
• Primary immunodeficiencies such as common variable immunodeficiency may present with elevated total IgG despite functional antibody deficiency; functional antibody responses (e.g., to pneumococcal vaccine) should be assessed when infections persist. 14
• IgG subclass deficiencies can coexist with normal or elevated total IgG levels and may contribute to infection risk. 14

Indications for Immunoglobulin Replacement Therapy

• IgG replacement therapy is indicated for primary hypogammaglobulinemia (typically IgG < 500 mg/dL) accompanied by recurrent infections; an elevated IgG level of 1,870 mg/dL does not meet criteria for replacement. 14

Monitoring and Laboratory Method Consistency

• Because systematic differences exist between electrophoretic and nephelometric quantification, especially at high IgG concentrations (> 1,920 mg/dL) where electrophoresis may underestimate values, the same laboratory method should be used consistently for longitudinal monitoring. 12